- Home
- FCPT vs ACAD Comparison
FCPT vs ACAD Comparison
Compare FCPT & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCPT
- ACAD
- Stock Information
- Founded
- FCPT 2015
- ACAD 1993
- Country
- FCPT United States
- ACAD United States
- Employees
- FCPT N/A
- ACAD N/A
- Industry
- FCPT Real Estate Investment Trusts
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- FCPT Real Estate
- ACAD Health Care
- Exchange
- FCPT Nasdaq
- ACAD Nasdaq
- Market Cap
- FCPT 2.9B
- ACAD 2.5B
- IPO Year
- FCPT N/A
- ACAD 2004
- Fundamental
- Price
- FCPT $27.71
- ACAD $21.57
- Analyst Decision
- FCPT Buy
- ACAD Buy
- Analyst Count
- FCPT 7
- ACAD 14
- Target Price
- FCPT $30.00
- ACAD $27.08
- AVG Volume (30 Days)
- FCPT 514.7K
- ACAD 3.0M
- Earning Date
- FCPT 04-30-2025
- ACAD 05-07-2025
- Dividend Yield
- FCPT 5.14%
- ACAD N/A
- EPS Growth
- FCPT 0.89
- ACAD N/A
- EPS
- FCPT 1.07
- ACAD 1.37
- Revenue
- FCPT $273,082,000.00
- ACAD $996,283,000.00
- Revenue This Year
- FCPT $7.79
- ACAD $13.49
- Revenue Next Year
- FCPT $9.81
- ACAD $10.58
- P/E Ratio
- FCPT $25.82
- ACAD $15.76
- Revenue Growth
- FCPT 6.21
- ACAD 22.42
- 52 Week Low
- FCPT $23.76
- ACAD $13.40
- 52 Week High
- FCPT $30.93
- ACAD $25.23
- Technical
- Relative Strength Index (RSI)
- FCPT 49.27
- ACAD 68.70
- Support Level
- FCPT $26.93
- ACAD $21.95
- Resistance Level
- FCPT $27.40
- ACAD $22.62
- Average True Range (ATR)
- FCPT 0.39
- ACAD 1.21
- MACD
- FCPT 0.02
- ACAD 0.23
- Stochastic Oscillator
- FCPT 72.26
- ACAD 56.27
About FCPT Four Corners Property Trust Inc.
Four Corners Property Trust Inc is a real estate investment trust predominantly engaged in the ownership, acquisition and leasing of restaurant and retail properties. The company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries. The firm operates through two segments namely, real estate operations and restaurant operations. The real estate operations segment consists of rental revenues generated by leasing restaurant and retail properties to tenants. The restaurant operations segment is conducted through a taxable REIT subsidiary (TRS) and consists of Kerrow Restaurant Operating Business. The firm generates majority of the revenue from the real estate operations segment.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.